PHA Classroom: e-Learning. Anytime. Anyplace.


>>Back to All Recordings

>>Back to About PH Recordings
>>Back to 2012 Conference Session Recordings

Session Recording from PHA's 2012 10th International PH Conference
Changing to Different PH Medications: Important Things to Know Before, During and After

June 23, 2012

A wealth of effective and approved PH medications are currently available to PH patients, and new medications are on the way. For patients already on a medication, there may be a reason to switch to another medication, such as failure to improve, side effects or the complex nature of some medications. In this session, we will explore and discuss questions around the issue of switching between PH medications.

Presenter Information

David Badesch, MD, University of Colorado Health Sciences Center School of Medicine, Aurora, Colo. (Chair); Cheryl Abbott, RN, CCRP, University of Colorado Denver, Aurora Colo.; Stephen Mathai, MD, MHS, Johns Hopkins University, School of Medicine, Baltimore, Md.; Hunter Champion, MD, University of Pittsburgh, Pittsburgh, Pa.

 

 

 

DIAMOND
SUPPORTER

PLATINUM
SUPPORTER

GOLD
SUPPORTER

SILVER
SUPPORTER

Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. United Therapeutics Corporation Bayer HealthCare
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.

 

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy   Virtual Tour of Website    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2014 Pulmonary Hypertension Association. All Rights Reserved.

NORD

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.